HOWL
Price
$0.92
Change
-$0.08 (-8.00%)
Updated
Dec 1 closing price
Capitalization
44.7M
107 days until earnings call
Intraday BUY SELL Signals
INAB
Price
$1.96
Change
-$0.02 (-1.01%)
Updated
Dec 1 closing price
Capitalization
9.04M
Intraday BUY SELL Signals
Interact to see
Advertisement

HOWL vs INAB

Header iconHOWL vs INAB Comparison
Open Charts HOWL vs INABBanner chart's image
Werewolf Therapeutics
Price$0.92
Change-$0.08 (-8.00%)
Volume$639.58K
Capitalization44.7M
IN8bio
Price$1.96
Change-$0.02 (-1.01%)
Volume$68.07K
Capitalization9.04M
HOWL vs INAB Comparison Chart in %
HOWL
Daily Signal:
Gain/Loss:
INAB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HOWL vs. INAB commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a StrongBuy and INAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 02, 2025
Stock price -- (HOWL: $0.92 vs. INAB: $1.95)
Brand notoriety: HOWL and INAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 67% vs. INAB: 93%
Market capitalization -- HOWL: $44.7M vs. INAB: $9.04M
HOWL [@Biotechnology] is valued at $44.7M. INAB’s [@Biotechnology] market capitalization is $9.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whileINAB’s FA Score has 1 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • INAB’s FA Score: 1 green, 4 red.
According to our system of comparison, both HOWL and INAB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 6 TA indicator(s) are bullish while INAB’s TA Score has 4 bullish TA indicator(s).

  • HOWL’s TA Score: 6 bullish, 4 bearish.
  • INAB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than INAB.

Price Growth

HOWL (@Biotechnology) experienced а -5.71% price change this week, while INAB (@Biotechnology) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.58%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +56.80%.

Reported Earning Dates

HOWL is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+1.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOWL($44.7M) has a higher market cap than INAB($9.04M). HOWL YTD gains are higher at: -37.777 vs. INAB (-74.728). INAB has higher annual earnings (EBITDA): -20.28M vs. HOWL (-66.34M). HOWL has more cash in the bank: 77.6M vs. INAB (13.2M). INAB has less debt than HOWL: INAB (3.12M) vs HOWL (37.1M). HOWL (0) and INAB (0) have equivalent revenues.
HOWLINABHOWL / INAB
Capitalization44.7M9.04M495%
EBITDA-66.34M-20.28M327%
Gain YTD-37.777-74.72851%
P/E RatioN/AN/A-
Revenue00-
Total Cash77.6M13.2M588%
Total Debt37.1M3.12M1,190%
TECHNICAL ANALYSIS
Technical Analysis
HOWLINAB
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signal:
Gain/Loss:
INAB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPCAF1.22N/A
N/A
Cathay Pacific Airways, Ltd.
GTHP0.25N/A
N/A
Guided Therapeutics, Inc.
MAYNF2.36N/A
N/A
Mayne Pharma Ltd.
ALSSF2.68N/A
N/A
Alsea SA
BKFAF7.01N/A
N/A
BROOKFIELD CORP.

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
-1.52%
IDYA - INAB
47%
Loosely correlated
-3.71%
SNTI - INAB
37%
Loosely correlated
-7.62%
SNSE - INAB
37%
Loosely correlated
-0.12%
ZNTL - INAB
34%
Loosely correlated
-4.55%
HOWL - INAB
32%
Poorly correlated
-7.91%
More